- Home
- LXEO vs VOR Comparison
LXEO vs VOR Comparison
Compare LXEO & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEO
- VOR
- Stock Information
- Founded
- LXEO 2017
- VOR 2015
- Country
- LXEO United States
- VOR United States
- Employees
- LXEO N/A
- VOR N/A
- Industry
- LXEO
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- LXEO
- VOR Health Care
- Exchange
- LXEO Nasdaq
- VOR Nasdaq
- Market Cap
- LXEO 140.6M
- VOR 134.8M
- IPO Year
- LXEO 2023
- VOR 2021
- Fundamental
- Price
- LXEO $2.71
- VOR $0.65
- Analyst Decision
- LXEO Strong Buy
- VOR Strong Buy
- Analyst Count
- LXEO 5
- VOR 7
- Target Price
- LXEO $22.20
- VOR $9.43
- AVG Volume (30 Days)
- LXEO 1.4M
- VOR 235.2K
- Earning Date
- LXEO 05-08-2025
- VOR 05-08-2025
- Dividend Yield
- LXEO N/A
- VOR N/A
- EPS Growth
- LXEO N/A
- VOR N/A
- EPS
- LXEO N/A
- VOR N/A
- Revenue
- LXEO N/A
- VOR N/A
- Revenue This Year
- LXEO N/A
- VOR N/A
- Revenue Next Year
- LXEO N/A
- VOR N/A
- P/E Ratio
- LXEO N/A
- VOR N/A
- Revenue Growth
- LXEO N/A
- VOR N/A
- 52 Week Low
- LXEO $1.45
- VOR $0.49
- 52 Week High
- LXEO $19.50
- VOR $1.95
- Technical
- Relative Strength Index (RSI)
- LXEO 48.48
- VOR 38.81
- Support Level
- LXEO $1.90
- VOR $0.49
- Resistance Level
- LXEO $2.64
- VOR $0.75
- Average True Range (ATR)
- LXEO 0.48
- VOR 0.07
- MACD
- LXEO 0.02
- VOR 0.02
- Stochastic Oscillator
- LXEO 51.43
- VOR 59.04
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.